Department of Vascular and Endovascular Surgery, Klinikum rechts der Isar and Munich Aortic Centre, Technical University Munich, Munich, Germany.
Br J Surg. 2018 Mar;105(4):379-387. doi: 10.1002/bjs.10714. Epub 2018 Feb 8.
There is increasing awareness that women may have worse outcomes following repair of abdominal aortic aneurysm (AAA). The aim of this study was to analyse the association between sex, age and in-hospital mortality after AAA using hospital episode data collected routinely at the nationwide level.
Data were extracted from the nationwide statutory Diagnosis Related Group statistics provided by the German Federal Statistical Office. Patients with a diagnosis of intact (non-ruptured) AAA (ICD-10 GM I71.4) and procedure codes (OPS; 2005-2013) for endovascular aneurysm repair (EVAR) (5-38a.1*) or open aneurysm repair (5-384.5, 5-384.7), treated from 2005 to 2013, were included. A multilevel multivariable regression model was applied to adjust for medical risk (using the Elixhauser co-morbidity score), type of procedure, type of admission, and to account for clustering of patients within centres. The primary outcome was in-hospital mortality.
Some 84 631 patients were identified, of whom 10 039 (11·9 per cent) were women. Women were significantly older than men at admission (median 74 (i.q.r. 69-80) versus 72 (66-77) years; P < 0·001). EVAR was used less frequently in women (48·1 versus 54·7 per cent; P < 0·001). The in-hospital mortality rate was higher in women, overall (5·0 versus 3·1 per cent; relative risk 1·60, 95 per cent c.i. 1·45 to 1·75), and for EVAR (2·8 versus 1·5 per cent; RR 1·90, 1·60 to 2·30) and open repair (6·8 versus 5·0 per cent; RR 1·36, 1·22 to 1·52). In-hospital mortality increased with age and was highest in patients aged over 80 years. In multivariable regression analysis, female sex (RR 1·20, 1·07 to 1·35) and age per 10-year increase (RR 1·83, 1·73 to 1·95) were independent risk factors for higher in-hospital mortality.
In Germany, women were older when undergoing AAA repair and were less likely to receive EVAR. Mortality rates were higher in older patients and in women, irrespective of the surgical technique used.
越来越多的人意识到,女性在接受腹主动脉瘤(AAA)修复后可能会出现更差的结果。本研究的目的是使用全国范围内常规收集的医院病例数据,分析性别、年龄与 AAA 后院内死亡率之间的关系。
从德国联邦统计局提供的全国法定诊断相关组统计数据中提取数据。纳入 2005 年至 2013 年间接受诊断为完整(未破裂)AAA(ICD-10 GM I71.4)和手术编码(OPS;2005-2013 年)的血管内动脉瘤修复(EVAR)(5-38a.1*)或开放动脉瘤修复(5-384.5、5-384.7)的患者。采用多水平多变量回归模型调整医疗风险(使用 Elixhauser 合并症评分)、手术类型、入院类型,并考虑到中心内患者的聚类。主要结局是院内死亡率。
共确定了 84631 名患者,其中 10039 名(11.9%)为女性。女性在入院时明显比男性年龄大(中位数 74(IQR 69-80)比 72(66-77)岁;P<0.001)。女性接受 EVAR 的比例较低(分别为 48.1%和 54.7%;P<0.001)。女性总体院内死亡率较高(5.0%比 3.1%;相对风险 1.60,95%置信区间 1.45 至 1.75),且 EVAR(2.8%比 1.5%;RR 1.90,1.60 至 2.30)和开放修复(6.8%比 5.0%;RR 1.36,1.22 至 1.52)。院内死亡率随年龄增长而增加,80 岁以上患者死亡率最高。多变量回归分析显示,女性(RR 1.20,1.07 至 1.35)和每增加 10 岁(RR 1.83,1.73 至 1.95)是院内死亡率较高的独立危险因素。
在德国,女性在接受 AAA 修复时年龄较大,且不太可能接受 EVAR。高龄患者和女性的死亡率较高,与手术技术无关。